CD49b (ITGA2) human monoclonal antibody, clone B4F12
Applications | ELISA, FC, IF |
Reactivities | Human |
CD49b (ITGA2) human monoclonal antibody, clone B4F12
Applications | ELISA, FC, IF |
Reactivities | Human |
Recombinant Anti-CD40L (Clone hu5c8 (Ruplizumab))
Applications | Bl, FC, WB |
Reactivities | Human |
Recombinant Anti-Human Ephrin Type A receptor 2 (Clone 1C1)
Applications | ELISA, FC, IF, WB |
Reactivities | Human |
Recombinant Anti-TNF alpha (Clone CDP 571 (Humicade))
Applications | ELISA |
Reactivities | Human |
Recombinant Anti-TNF alpha (Clone D2E7 (Adalimumab))
Applications | Bl, ELISA, IF, IHC |
Reactivities | Human |
Anti-Modified cytokeratin [COU-1], Human IgM, kappa
Applications | ELISA, ICC, IHC, WB |
Reactivities | Human |
Anti-Laminin-2 LG5 [C3_Hu10], Human IgG1, kappa
Applications | ELISA, FC, IF, WB |
Reactivities | Human, Mouse |
SARS-CoV-2 monoclonal antibody (CB6 biosimilar)
Applications | ELISA, FC |
Reactivities | SARS-CoV-2 |
SARS-CoV monoclonal antibody (CR3022 biosimilar)
Applications | ELISA, FC |
Reactivities | SARS-CoV-2 |
Chikungunya virus human monoclonal antibody, clone E26D9
Applications | IF, Neutralize |
Reactivities | Human |
Chikungunya virus human monoclonal antibody, clone E26D9
Applications | IF, Neutralize |
Reactivities | Human |
Recombinant Anti-CD11a (Clone hu1124 (Efalizumab))
Applications | Bl, FC |
Reactivities | Human |
Recombinant Anti-TNF alpha (Clone cA2 (Infliximab))
Applications | ELISA, FC |
Reactivities | Human |
Anti-NKp46 [Bab281], Human IgG1, kappa
Applications | FC, IF, IP |
Reactivities | Human, Macaque |
Modifications | This chimeric human antibody was made using the variable domain sequences of the original Mouse IgG1 format for improved compatibility with existing reagents assays and techniques. |
Recombinant Anti-erbB-2 (Her-2/neu) (Clone 4D5-8 (trastuzumab))
Applications | ELISA, FC, IHC |
Reactivities | Human |